Chang Flora, O'Hare Ann M, Miao Yinghui, Steinman Michael A
School of Medicine, University of California at Davis, Davis, California.
Division of Geriatrics, University of California San Francisco, San Francisco, California.
J Am Geriatr Soc. 2015 Nov;63(11):2290-7. doi: 10.1111/jgs.13790. Epub 2015 Oct 27.
To determine how many ambulatory older adults with chronic kidney disease receive medications that are contraindicated or dosed excessively given their level of renal function.
Cross-sectional retrospective study.
U.S. Department of Veterans Affairs (VA) clinics.
Individuals aged 65 and older with a creatinine clearance (CrCl) of 15 to 49 mL/min (N = 83,850; mean age 80; 96% male).
Forty medications that require dose adjustment or are contraindicated in people with impaired renal function were examined. Medication use and CrCl (calculated using the Cockroft-Gault equation) were assessed using VA pharmacy, laboratory, and other data sources as of October 2007.
Thirteen percent of older veterans with a CrCl of 30 to 49 mL/min and 32% of those with a CrCl of 15 to 29 mL/min received one or more drugs that were contraindicated or prescribed at an excessive dose given the individual's level of renal function. The strongest risk factor for renally inappropriate prescribing was number of medications used; the risk of receiving renally inappropriate medications was 5.5 times as high (95% confidence interval = 5.1-5.9) in older adults taking 10 or more medications as in those taking one to three medications. Ranitidine, allopurinol, and metformin together accounted for 76% of renally misprescribed medications in individuals with a CrCl of 30 to 49 mL/min. Glyburide, ranitidine, gemfibrozil, carvedilol, and allopurinol accounted for 47% of renally misprescribed drugs for individuals with a CrCl of 15 to 29 mL/min.
Inappropriate prescribing of renally cleared medications is common in ambulatory older veterans, with only a few medications accounting for most of these prescribing problems.
确定有多少患有慢性肾病的非卧床老年患者所服用的药物,鉴于其肾功能水平,是禁忌用药或剂量过量。
横断面回顾性研究。
美国退伍军人事务部(VA)诊所。
年龄在65岁及以上,肌酐清除率(CrCl)为15至49 mL/分钟的个体(N = 83,850;平均年龄80岁;96%为男性)。
检查了40种需要调整剂量或在肾功能受损患者中禁忌使用的药物。截至2007年10月,使用VA药房、实验室及其他数据来源评估药物使用情况和CrCl(使用Cockcroft-Gault方程计算)。
CrCl为30至49 mL/分钟的老年退伍军人中,13%的人以及CrCl为15至29 mL/分钟的人中,32%的人服用了一种或多种鉴于个体肾功能水平属于禁忌或剂量过量的药物。肾用药不当的最强风险因素是所使用药物的数量;服用10种或更多药物的老年人接受肾用药不当药物的风险是服用1至3种药物的老年人的5.5倍(95%置信区间 = 5.1 - 5.9)。对于CrCl为30至49 mL/分钟者,雷尼替丁、别嘌醇和二甲双胍共同占肾用药不当药物的76%。对于CrCl为15至29 mL/分钟者,格列本脲、雷尼替丁、吉非贝齐、卡维地洛和别嘌醇占肾用药不当药物的47%。
在非卧床老年退伍军人中,经肾脏清除药物的用药不当情况很常见,少数几种药物占了这些用药问题的大部分。